OP
TLSI icon

Omni Partners’s TriSalus Life Sciences TLSI Stock Holding History

Omni Partners’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.95M Buy
+201,612
New +$2.04M 0.1% 110

Other funds holding TLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Omni Partners's TLSI Position: Q1 2021 in Review

Omni Partners opened a new position in TriSalus Life Sciences (TLSI) in Q1 2021: 201,612 shares worth $1.95M. The stake represents 0.1% of the portfolio and ranks #110 among its holdings.

44 funds tracked by Wall St. Rank hold TLSI as of Q1 2021.

  • Omni Partners held 201,612 shares of TriSalus Life Sciences worth $1.95M as of Q1 2021.
  • TriSalus Life Sciences was a new Omni Partners position in Q1 2021.
  • TriSalus Life Sciences made up 0.1% of Omni Partners's portfolio in Q1 2021, its #110 holding.
  • 44 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2021.

Based on Omni Partners's 13F filing for Q1 2021, filed 17 May 2021.